Richard E. Scranton - Concepedia

Author

Richard E. Scranton

Also Known As

R SCRANTON, R Scranton, R. E. Scranton, R. Scranton, R.E. Scranton, Richard .E. Scranton, Richard E Scranton, Richard E. Scranton, Richard Scranton

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Brigham and Women's Hospital Harvard University VA Boston Healthcare System Veroscience (United States)Pacira (United States)

About

Richard E. Scranton is an author at Brigham and Women's Hospital specializing in medicine, public health, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	271
2	Public Health	3	3	258
3	Epidemiology	3	3	258
4	Diabetes	2	2	94
5	Health Sciences	1	1	21

Richard E. Scranton

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes J. Michael Gaziano, Anthony H. Cincotta, Christopher M. O’Connor, Diabetes Care	2010	210
The Association Between Statins and Cancer Incidence in a Veterans Population Wildon Farwell, Richard E. Scranton, Elizabeth Lawler, JNCI Journal of the National Cancer Institute	2008	197
Veteran's affairs hospital discharge databases coded serious bacterial infections accurately Sebastian Schneeweiß, Ari Robicsek, Richard E. Scranton, Journal of Clinical Epidemiology Serious Bacterial InfectionsEpidemiologyClinical DatabaseMedicineHealthcare-associated Infection	2006	172
Impact of postsurgical opioid use and ileus on economic outcomes in gastrointestinal surgeries Tong J. Gan, Scott B. Robinson, Gary M. Oderda, Current Medical Research and Opinion	2015	114
Statins and Prostate Cancer Diagnosis and Grade in a Veterans Population Wildon Farwell, Richard E. Scranton, Elizabeth Lawler, JNCI Journal of the National Cancer Institute	2011	107
Bromocriptine – unique formulation of a dopamine agonist for the treatment of type 2 diabetes Richard E. Scranton, Anthony H. Cincotta Expert Opinion on Pharmacotherapy	2009	95
Effect of Bromocriptine‐QR (a Quick‐Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects J. Michael Gaziano, Anthony H. Cincotta, Aaron I. Vinik, Journal of the American Heart Association	2012	92
Statin Use and Fracture Risk Richard E. Scranton, Melissa Young, Elizabeth Lawler, Archives of Internal Medicine	2005	75
Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study Gladys Ting, Sebastian Schneeweiß, Richard E. Scranton, Arthritis Research & Therapy	2008	62
40th EASD Annual Meeting of the European Association for the Study of Diabetes M. Veitenhansl, K. Stegner, F. X. Hierl, Diabetologia Metabolic SyndromeDiabetes ManagementDiabetes EpidemiologyHealth PolicyGlobal Health	2004	61

Page 1